Whalesbook
Morgan Stanley has maintained an 'underweight' rating on Dixon Technologies, setting a target price of ₹8,157. The brokerage cited concerns over revenue growth sustainability, rising competition in the electronics manufacturing services (EMS) sector, and delays in government PLI incentives. This comes after the company reported a 36% decline in Q4 FY26 net profit despite a modest rise in revenue. Investors are now closely monitoring the impact of new market entrants, pending regulatory approvals, and margin pressure.
What Happened
Morgan Stanley has reiterated an 'underweight' rating on Dixon Technologies, a major player in the electronics manufacturing services (EMS) sector. The brokerage firm has set a target price of ₹8,157 for the stock. This stance is primarily driven by concerns regarding the sustainability of the company's revenue growth, which analysts believe may face headwinds beyond the 2028 financial year. Additionally, the brokerage highlighted increasing competitive pressures and delays in receiving benefits from the government's Production-Linked Incentive (PLI) scheme for mobile components.
The Financial Performance
Dixon Technologies recently released its results for the quarter ending March 2026 (Q4 FY26). The company reported a 36.03% year-on-year decline in consolidated net profit, which fell to ₹256.41 crore from ₹400.82 crore in the same period the previous year. While the bottom line saw a sharp drop, revenue from operations showed a modest growth of 2.12%, reaching ₹10,510.51 crore. A key factor influencing these results was a rise in total expenses, which increased to ₹10,230.77 crore from ₹9,981.92 crore a year earlier.
The Growth Sustainability Debate
A central point in the brokerage's cautious view is whether Dixon Technologies can continue to achieve revenue growth above 20-25% beyond FY28. The competitive landscape is becoming more challenging, with new players entering the market. For instance, Amber Enterprises has announced a partnership with OPPO India, and engineering major Larsen & Toubro (L&T) has entered the industrial EMS space. As these companies expand their presence, Dixon faces the challenge of defending its market share in its primary business verticals.
Regulatory and Execution Hurdles
The company is also navigating specific operational and regulatory bottlenecks. Benefits from the mobile component PLI scheme, which are crucial for margin expansion, are now expected to materialize only in the second half of FY27. Furthermore, the mobile segment, which accounts for 78% of the company's revenue as of FY26, is currently facing pressure from global memory chip availability and pricing. Investors are also waiting for updates on the joint venture with Chinese smartphone maker Vivo, which is still pending approval. While some market estimates have already factored in the potential impact of this partnership, the delay remains a point of observation.
What Investors Should Track
Going forward, the key monitorables for shareholders include the company's ability to navigate rising competition and whether it can maintain its margins amidst higher operational costs. The timeline for the realization of PLI benefits and the final approval of the Vivo joint venture will be critical. Additionally, investors may look for management commentary on how the company plans to sustain its growth trajectory in the face of new entrants in the industrial and consumer electronics EMS spaces.
